as of Oct 22
AFL
GrowthAFLAC INC
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan.
Close · 3M
+3.04%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
LQAI · New entry · 1d
weight 0 → 0.480% (new)·stock down 2.5% in the 30 days before
Sep 29·entry $113.66·now $120.51Drifting
LQAI · Exit · 1d
weight 0.130% → 0 (exited)·stock up 2.2% in the 30 days before
Jun 9·entry $115.61·now $120.51
LQAI · New entry · 1d
weight 0 → 0.130% (new)·stock up 3.6% in the 30 days before
May 12·entry $116.16·now $120.51Drifting
AIEQ · Exit · 1d
weight 4.330% → 0 (exited)·stock down 4.2% in the 30 days before
Oct 1·entry $111.18·now $120.51
AIEQ · Weight decrease · 2d
weight 4.360% → 4.300% (-0.060 pp)·stock down 3.2% in the 30 days before
Sep 27·entry $113.55·now $120.51
AIEQ · Weight decrease · 2d
weight 4.420% → 4.320% (-0.100 pp)·stock down 2.5% in the 30 days before
Sep 23·entry $115.23·now $120.51
AIEQ · Weight decrease · 2d
weight 4.480% → 4.420% (-0.060 pp)·stock down 0.2% in the 30 days before
Sep 18·entry $116.33·now $120.51
AIEQ · Weight increase · 2d
weight 4.340% → 4.480% (+0.140 pp)·stock down 3.4% in the 30 days before
Sep 16·entry $116.81·now $120.51Drifting
AIEQ · Weight increase · 2d
weight 4.320% → 4.360% (+0.040 pp)·stock down 4.5% in the 30 days before
Sep 11·entry $115.28·now $120.51Drifting
AIEQ · Weight increase · 3d
weight 0.050% → 4.370% (+4.320 pp)·stock down 7.5% in the 30 days before
Sep 4·entry $117.21·now $120.51Drifting
AIEQ · Weight increase · 2d
weight 0.050% → 4.350% (+4.300 pp)·stock down 5.7% in the 30 days before
Sep 3·entry $118.36·now $120.51Fresh
AIEQ · Sudden change · 1d
weight 0.050% → 4.310% (+4.260 pp)·stock down 8.4% in the 30 days before
Sep 1·entry $116.02·now $120.51
AIEQ · Weight decrease · 3d
weight 1.880% → 0.290% (-1.590 pp)·stock down 3.3% in the 30 days before
May 30·entry $112.11·now $120.51
AIEQ · Weight decrease · 2d
weight 1.880% → 1.820% (-0.060 pp)·stock down 3.1% in the 30 days before
May 28·entry $112.63·now $120.51
AIEQ · Weight decrease · 2d
weight 1.920% → 1.880% (-0.040 pp)·stock up 2.4% in the 30 days before
May 24·entry $116.82·now $120.51
AIEQ · Weight increase · 2d
weight 1.880% → 1.920% (+0.040 pp)·stock up 1.1% in the 30 days before
May 20·entry $117.22·now $120.51Drifting
AIEQ · New entry · 1d
weight 0 → 1.860% (new)·stock up 3.0% in the 30 days before
May 3·entry $113.33·now $120.51Drifting
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.
Buffett-style framework
AI ETF AIEQ has shown a recent trend of decreasing its weight in AFLAC, suggesting a cautious or negative sentiment. This contrasts with the 'Pass' assessment for the company's business model and moat but aligns with the overall 'Fail' verdict, which is driven by an inability to confirm fundamental quality aspects like management and financial health due to insufficient data.
- Circle of CompetenceThe life and health insurance industry, particularly with a focus on supplemental products like AFLAC's, typically offers predictable unit economics suitable for long-term cash flow projections within the circle of competence.
- Economic MoatAFLAC benefits from strong brand recognition, particularly in Japan, customer inertia in supplemental insurance, and scale advantages in underwriting and claims processing, which collectively form a durable economic moat.
- ManagementThe provided data does not offer sufficient detail on management's candor, capital allocation decisions (such as specific buyback effectiveness or M&A rationale), or skin in the game to make a definitive judgment.
- Financial HealthInsufficient data is provided to assess the 10-year average ROE, stability of operating margins, specific debt profile, or consistent owner earnings, which are all critical for a thorough financial health assessment.
- Margin of SafetyThe current PER of 11.73, combined with recent revenue growth of 13.64% YoY, suggests a potentially attractive valuation that could offer a margin of safety, assuming the underlying earnings power is durable.
While AFLAC's business model falls within the circle of competence and possesses a durable economic moat, a definitive judgment on its financial health and management quality cannot be made due to a lack of sufficient data. This inability to confirm critical aspects of a 'wonderful company' leads to an overall 'Fail' verdict, despite a potentially attractive current valuation.
Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.